Immuneel

Immuneel Therapeutics Private Limited

Bengaluru, India · $49.9M raised

Headquarters
Bengaluru
Employees
11–50
Business Model
B2C
Total Funding
$49.9M
Last Round
$12.0M Series BJun 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Immuneel Therapeutics is a Bengaluru-based cell and gene therapy company building affordable CAR-T and advanced cellular therapies for cancer patients in India and globally. Co-founded with backing from prominent Indian biotech and industry figures, Immuneel operates an integrated model spanning clinical development and in-house manufacturing, aimed at closing the access gap that keeps approved cell therapies out of reach in emerging markets. The company partners with international cell-therapy developers to localise and deliver treatments at substantially lower cost. Recognition includes Most Promising Cell & Gene Therapy Startup in APAC (Asia Pacific Cell & Gene Therapy Excellence Awards 2023), Innovation in Cell and Gene Therapy at the Endpoints 11 Awards and BioPharma Honours 2023, and the CGCS Pioneers Award at the International Cell & Gene Therapy China Summit 2024.

Summary

Immuneel is a Biotech company based in Bengaluru, India. It has raised $49.9M in total across 5 rounds, most recently a $12.0M Series B round in Jun 2026. Investors include Singularity AMC, Rainmatter and Eight Roads Ventures.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BJun 2026
$12.0M

Sign up to see all 5 events

Funding: Seed through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Immuneel on Indexed.vc
<a href="https://indexed.vc/companies/immuneel"><img src="https://indexed.vc/api/badge/company/immuneel" alt="Immuneel on Indexed.vc" width="260" height="76" /></a>